Pneumonia Vaccine
From 1 July 2026, the Australian Government will introduce the 21-valent pneumococcal conjugate vaccine (21vPCV), Capvaxive®, to the National Immunisation Program.
The new vaccine will replace both Prevenar 13® and Pneumovax 23® for adults, streamlining the pneumococcal vaccination schedule while providing protection against a broader range of pneumococcal disease strains.
Under the updated program, Capvaxive® will be available free of charge through the NIP for:
Adults aged 65 years and over
Aboriginal and Torres Strait Islander adults aged 25 years and over
Adults aged 18 years and over with specified medical conditions that increase their risk of severe pneumococcal disease
Hamilton Doctors is stocking the new Capvaxive injection.
Menopause Clinic

Hamilton Doctors acknowledges and respect’s the traditional custodians of this land and pay our respects to the traditional owners past and present.
Copyright - Hamilton Doctors - 2026